Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA593667
Max Phase: Preclinical
Molecular Formula: C15H10BrN
Molecular Weight: 284.16
Molecule Type: Small molecule
Associated Items:
ID: ALA593667
Max Phase: Preclinical
Molecular Formula: C15H10BrN
Molecular Weight: 284.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Brc1ccc2c(c1)Cc1c-2[nH]c2ccccc12
Standard InChI: InChI=1S/C15H10BrN/c16-10-5-6-11-9(7-10)8-13-12-3-1-2-4-14(12)17-15(11)13/h1-7,17H,8H2
Standard InChI Key: UDCPKOZAKWHAJJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 284.16 | Molecular Weight (Monoisotopic): 282.9997 | AlogP: 4.50 | #Rotatable Bonds: 0 |
Polar Surface Area: 15.79 | Molecular Species: NEUTRAL | HBA: 0 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.73 | CX Basic pKa: | CX LogP: 4.53 | CX LogD: 4.53 |
Aromatic Rings: 3 | Heavy Atoms: 17 | QED Weighted: 0.49 | Np Likeness Score: -0.17 |
1. Talaz O, Gülçin I, Göksu S, Saracoglu N.. (2009) Antioxidant activity of 5,10-dihydroindeno[1,2-b]indoles containing substituents on dihydroindeno part., 17 (18): [PMID:19683932] [10.1016/j.bmc.2009.07.077] |
2. Ekinci D, Cavdar H, Durdagi S, Talaz O, Sentürk M, Supuran CT.. (2012) Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI., 49 [PMID:22245047] [10.1016/j.ejmech.2011.12.022] |
Source(1):